Andrea Malaspina
UCL Queen Square Institute Of Neurology, Queen Square
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 111 publications
Targeting TDP-43 in sporadic amyotrophic lateral sclerosis.
Journal: Journal of neurology
Published: May 06, 2026
Predicting Phenoconversion to Clinically Manifest ALS: Results of a Large-Scale Proteomic Study.
Journal: medRxiv : the preprint server for health sciences
Published: December 18, 2025
Longitudinal plasma proteomics predict phenoconversion to clinically manifest ALS.
Journal: Nature medicine
Published: December 01, 2025
Moving past NfL? Multibiomarker models for ALS prognosis and stratification.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: July 21, 2025
The metabolic intersection between immunosenescence and neuroinflammation in amyotrophic lateral sclerosis.
Journal: Journal of inflammation (London, England)
Published: July 14, 2025
IsomiR Utility in Amyotrophic Lateral Sclerosis Prognostication.
Journal: medRxiv : the preprint server for health sciences
Published: June 04, 2025
IsomiR utility in amyotrophic lateral sclerosis prognostication.
Journal: Med (New York, N.Y.)
Published: May 28, 2025
Skeletal muscle biomarkers of amyotrophic lateral sclerosis: a large-scale, multi-cohort proteomic study.
Journal: medRxiv : the preprint server for health sciences
Published: May 02, 2025
Glutathione oxidation in cerebrospinal fluid as a biomarker of oxidative stress in amyotrophic lateral sclerosis.
Journal: Translational neurodegeneration
Published: April 14, 2025
Last Updated: 09/26/2026